Patents by Inventor Michael Agrez

Michael Agrez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACTIVATING AGENTS
    Publication number: 20260103488
    Abstract: The present invention related to compositions and methods for activating Lck, including in vivo, in vitro and ex vivo uses.
    Type: Application
    Filed: September 27, 2024
    Publication date: April 16, 2026
    Applicant: Interk Peptide Therapeutics Limited
    Inventor: Michael Agrez
  • Peptide Activating Agent
    Publication number: 20250019397
    Abstract: The present invention is related to compositions and methods for activating Lck, including in vivo, in vitro and ex vivo uses.
    Type: Application
    Filed: January 17, 2024
    Publication date: January 16, 2025
    Applicant: Interk Peptide Therapeutics Limited
    Inventor: Michael Agrez
  • COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNITY, INCLUDING AUTOIMMUNITY ASSOCIATED WITH CANCER AND CANCER THERAPY
    Publication number: 20240358790
    Abstract: The present invention related to methods and compositions for maintaining IL-2 homeostasis, including low levels CN of IL-2, in a subject, for treating autoimmune disorders. In a preferred embodiment, the composition comprises 2-amino-dodecanoic acid (2Adod)-conjugated peptides selected from RSKAKNPLYR-(2Adod)2-NH2, RSKAKNPLYR-(2ADod)4-NH2, or peptides with the same sequence where all residues are substituted with D-amino acids, conjugated to two or four 2Adod.
    Type: Application
    Filed: August 19, 2022
    Publication date: October 31, 2024
    Applicant: Interk Peptide Therapeutics Limited
    Inventor: Michael Agrez
  • Polypeptides And Methods For Improving Skin Conditions
    Publication number: 20220409510
    Abstract: The present invention relates to polypeptides, compositions and methods for preventing and/or treating skin conditions including dermal aging and skin conditions associated with UV exposure.
    Type: Application
    Filed: November 29, 2019
    Publication date: December 29, 2022
    Applicant: Interk Peptide Therapeutics Limited
    Inventor: Michael Agrez
  • Methods and Agents for the Treatment of Cancer
    Publication number: 20080058268
    Abstract: There are disclosed methods for prophylaxis or treatment of cancer in a mammal. The methods comprise administering an effective amount of an agent to the mammal, which binds to a MAP kinase or an integrin such that binding of the MAP kinase to the integrin is inhibited.
    Type: Application
    Filed: October 15, 2004
    Publication date: March 6, 2008
    Inventor: Michael Agrez
  • Map kinase integrin-binding domain
    Publication number: 20050214755
    Abstract: Dislosed is the integrin-binding domain of MAP kinase. Interaction between MAP kinase and integrin via this domain activates MAP kinase and initiates cellular activity. Methods of modulating cellular activity by inhibiting direct MAP kinase-integrin binding are provided. These methods have particular use in inhibiting growth of cancer cells.
    Type: Application
    Filed: December 21, 2001
    Publication date: September 29, 2005
    Inventors: Michael Agrez, Nuzhat Ahmed